1. Home
  2. NSYS vs SCLX Comparison

NSYS vs SCLX Comparison

Compare NSYS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NSYS

Nortech Systems Incorporated

N/A

Current Price

$11.42

Market Cap

40.1M

Sector

Technology

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$4.93

Market Cap

34.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
SCLX
Founded
1981
2011
Country
United States
United States
Employees
N/A
34
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
34.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NSYS
SCLX
Price
$11.42
$4.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.3K
★ 28.1K
Earning Date
05-13-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 80.85
N/A
EPS
★ 0.09
N/A
Revenue
$14,371,000.00
★ $30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
$124.78
★ N/A
Revenue Growth
★ 7.01
N/A
52 Week Low
$6.50
$4.20
52 Week High
$18.01
$29.84

Technical Indicators

Market Signals
Indicator
NSYS
SCLX
Relative Strength Index (RSI) 41.26 35.89
Support Level $11.23 $4.85
Resistance Level $12.21 $5.60
Average True Range (ATR) 0.47 0.31
MACD 0.07 0.04
Stochastic Oscillator 22.80 7.81

Price Performance

Historical Comparison
NSYS
SCLX

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: